Faculty Information

Present specialized field

BooK

Journal

Presentation

Belonging society

（Last updated : 2024-03-26 16:39:18）

Toru Oga
Department Kawasaki Medical School Kawasaki Medical School, Department of Respiratory Medicine,

Position Professor

■ Present specialized field

COPD, asthma, sleep medicine, respiratory failure, patient-reported outcome

■ BooK

1.	2022/02/02		Clinical Cases in Noninvasive Ventilation in Quality of Life., Teaching Pearls in Noninvasive Mechanical Ventilation
2.	2014/01/20		Longitudinal Changed in Dyspnea, DYSPNEA: Mechanisms, Measurement, and Management Therd Edition

■ Journal

1.	2023/05	Improving the diagnosis of chronic obstructive pulmonary disease starts with appropriate medical education.
2.	2023/05	One-year change in the health status predicts the subsequent hospitalization and mortality in patients waitlisted for lung transplantation in Japan.
3.	2023/04/01	Predictive value of serum high-mobility group box 1 levels for checkpoint inhibitor pneumonitis
4.	2023/03	Changes in mortality among patients with chronic obstructive pulmonary disease from the 1990s to the 2000s: a pooled analysis of two prospective cohort studies.
5.	2023/01/11	Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers
6.	2022/10	Filaggrin-deficient rats generated using zinc-finger nucleases spontaneously exhibit dry scaly skin.
7.	2022/08	HDL and sleep: beyond cardiovascular diseases and allergy.
8.	2022/04/15	Pneumococcal Pneumonia Co-infection with Mycobacterium avium and Nocardia cyriacigeorgica in an Immunocompetent Patient.
9.	2022/01	Sleep Apnea Syndrome (SAS) Clinical Practice Guidelines 2020.
10.	2021/12/26	Role of interleukin 5-induced eosinophilia in interleukin 33-triggered airway inflammation in mice
11.	2021/11	Comparison between tools for measuring breathlessness: Cross-sectional validation of the Japanese version of the Dyspnoea-12.
12.	2021/11	Tumor PD-L1 and VEGF Expression, and CD8 T Cell Infiltration Predict Clinical Response to Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
13.	2021/08	A novel automated immunoassay for serum NY-ESO-1 and XAGE1 antibodies in combinatory prediction of response to anti-programmed cell death-1 therapy in non-small-cell lung cancer
14.	2021/06	Prospective associations of sleep apnea, periodic limb movements, and plasma fibrinogen level.
15.	2021/04/21	Patient-reported dyspnea and health predict waitlist mortality in patients waiting for lung transplantation in Japan.
16.	2021/03	Sleep quality and its association with health-related quality of life of patients on lung transplantation waitlist in Japan.
17.	2021/02/01	Impact of sleep-disordered breathing on glucose metabolism among individuals with a family history of diabetes: the Nagahama study.
18.	2021/01	Generalized herpes zoster and cutaneous metastasis during chemotherapy for non-small cell lung cancer: A case report
19.	2020/11	Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging: a pooled analysis of individual patient data.
20.	2020/10	Successful treatment of gastric cancer after complete response of lung cancer by nivolumab: a case report
21.	2020/09	Sex differences between women and men with COPD: A new analysis of the 3CIA study
22.	2020/07	An unusual but unmissable link between summer-type hypersensitivity pneumonitis and asthma in an old house.
23.	2020/07	Role of serum periostin in severe obstructive sleep apnea with albuminuria: an observational study.
24.	2020/05/05	Analysis of Optimal Health-Related Quality of Life Measures in Patients Waitlisted for Lung Transplantation.
25.	2020/03	Analysis of optimal health-related quality of life measures in patients waitlisted for lung transplantation.
26.	2020/02	Detachment and recovery of an X-ray opaque tip of a disposable guide sheeth kit: A rare complication of endobronchial ultrasound-guided transbronchial biopsy.
27.	2020/01/15	Thoracoscopic Findings in IgG4-related Pleuritis.
28.	2020	Clinical Analysis of Pulmonary Mycobacterium kansasii Disease.
29.	2020	Mechanical insufflation-exsufflation-related bilateral pneumothorax
30.	2019/12	Comparison between electronic and paper versions of patient-reported outcome measures in subjects with chronic obstructive pulmonary disease: an observational study with a cross-over administration.
31.	2019/11/14	Pulmonary Mycobacterium avium complex disease requiring differentiation from recurrence of lung cancer during the follow-up period for lung cancer
32.	2019/11	A randomized controlled trial of telemedicine for long-term sleep apnea CPAP management.
33.	2019/09	Adrenal gland size in obstructive sleep apnea: Morphological assessment of hypothalamic pituitary adrenal axis activity.
34.	2019/07	How different are COPD-specific patient reported outcomes, health status, dyspnoea and respiratory symptoms? An observational study in a working population.
35.	2019/05	Low levels of PaO2 after long-term noninvasive ventilation are a poor prognostic factor in patients with restrictive thoracic disease.
36.	2019/03	Can the Sarcoidosis Health Questionnaire predict the long-term outcomes in Japanese sarcoidosis patients?
37.	2019/02	External validation and recalculation of the CODEX index in COPD patients. A 3CIAplus Cohort Study.
38.	2018/10	Comparison of patient-reported outcomes during acute exacerbations of chronic obstructive pulmonary disease.
39.	2018/08	Clinical significance of radiological pleuroparenchymal fibroelastosis pattern in interstitial lung disease patients registered for lung transplantation: a retrospective cohort study.
40.	2018/07	Impact of sleep characteristics and obesity on diabetes and hypertension across genders and menopausal status: the Nagahama study.
41.	2018/06	Gender differences in morphological and functional outcomes after mandibular setback surgery.
42.	2018/06	The relationship between cephalogram analysis and oxygen desaturation Index during sleep in patients submitted for mandibular setback surgery.
43.	2018/05	Health-related quality of life measurement in patients with chronic respiratory failure
44.	2018/04	Associations of obstructive sleep apnea with truncal skeletal muscle mass and density.
45.	2018/03	3CIA collaboration: Large-scale external validation and comparison of prognostic models: an application to chronic obstructive pulmonary disease
46.	2018/01	Impact of long-term continuous positive airway pressure on liver fat in male obstructive sleep apnea patients with fatty liver.
47.	2017	Analysis of the relationship between health status and mortality in hypercapnic patients with noninvasive ventilation.
48.	2017	Asymmetry in acute exacerbation of idiopathic pulmonary fibrosis.
49.	2017	Changes in habitual sleep duration after continuous positive airway pressure for obstructive sleep apnea.
50.	2017	Comparison of different disease-specific health-related quality of life measurements in patients with long-term noninvasive ventilation.
51.	2017	Frailty and patient-reported outcomes in subjects with chronic obstructive pulmonary disease: are they independent entities?
52.	2017	Importance of serial changes in biomarkers in idiopathic pulmonary fibrosis.
53.	2017	Initiatives BPCO, EABPCO, Leuven and 3CIA study groups. A simple algorithm for the identification of clinical COPD phenotypes.
54.	2017	Relationship between obstructive sleep apnea and endogenous carbon monoxide.
55.	2017	The association between health-related quality of life and disease progression in indiopathic pulmonary fibrosis: a prospective cohort study.
56.	2017	The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
57.	2017	Validation of the Japanese Severe Respiratory Insufficiency Questionnaire in hypercapnic patients with noninvasive ventilation.
58.	2016	Aquaporin-3 potentiates allergic airway inflammation in ovalbumin-induced murine asthma.
59.	2016	Changes in energy metabolism after continuous ositive airway pressure for obstructive sleep apnea.
60.	2016	Evaluation of bone mineral density by computed tomography in patients with obstructive sleep apnea.
61.	2016	Microalbuminuria in patients with obstructive sleep apnea-chronic obstructive pulmonary disease overlap syndrome.
62.	2016	Plasma incretin levels and depeptidyl peptidase-4 activity in patients with obstructive sleep apnea.
63.	2016	Platelet aggregability in patients with interstitial pneumonias.
64.	2016	Role of mitochondrial hydrogen peroxide induced by intermittent hypoxia in airway epithelial wound repair in vitro.
65.	2015	Among metabolic factors, significance of fasting and postprandial increases in acyl and desacyl ghrelin and the acyl/desacyl ratio in obstructive sleep apnea before and after treatment.
66.	2015	Association between endothelial function (assessed on reactive hyperemia peripheral arterial tonometry) and obstructive sleep apnea, visceral fat accumulation, and serum adiponectin.
67.	2015	Clinical impact of high-attenuation and cystic areas on computed tomography in fibrotic idiopathic interstitial pneumonias.
68.	2015	Impact of obstructive sleep apnea on liver fat accumulation according to sex and visceral obesity.
69.	2015	Lung allocation score and health-related quality of life in Japanese candidates for lung transplantation.
70.	2015	Matrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosis.
71.	2015	Obstructive sleep apnea and abdominal aortic calcification: Is there an association independent of comorbid risk factors?
72.	2015	The importance of stabilizing PaCO2 during Long-term non-invasive ventilation in subjects with COPD.
73.	2014	Associations among chronic obstructive pulmonary disease and sleep-disordered breathing in an urban male working population in Japan.
74.	2014	Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary disease.
75.	2014	Differences in associations between visceral fat accumulation and obstructive sleep apnea by sex.
76.	2014	Neutralization of leukotriene C4 and D4 activity by monoclonal and single-chain antibodies.
77.	2014	Obesity hypoventilation syndrome in Japan and independent determinants of arterial carbon dioxide levels.
78.	2014	Reanalysis of the Japanese experience using the combined COPD assessment of the 2011 GOLD classification.
79.	2014	The additive impact of periodic limb movements during sleep on inflammation in obstructive sleep apnea patients.
80.	2014	The importance of controlling PaCO₂ throughout long-term noninvasive ventilation.
81.	2014	Towards the next stage of novel biomarker discussion in COPD: Tekizai-Tekisho.
82.	2013	A prospective study analyzing one-year multidimensional outcomes in living lung transplant donors.
83.	2013	A urine biomarker for severe OSA patients: lipocaline-type prostaglandin D synthase.
84.	2013	Analysis of systemic and airway inflammation in obstructive sleep apnea.
85.	2013	Association between plasma neutrophil gelatinase associated lipocalin level and obstructive sleep apnea or nocturnal intermittent hypoxia.
86.	2013	Clinical relevance of plasma prostaglandin F_2a metabolite concentrations in patients with idiopathic pulmonary fibrosis.
87.	2013	Flexible positive airway pressure improves treatment adherence compared with auto-adjusting PAP.
88.	2013	HRCT findings as determinants of health-related quality of life in Mycobacterium avium complex disease.
89.	2013	Impaired endothelium-dependent vasodilator response in patients with pulmonary fibrosis.
90.	2013	Measurement of dyspnea in patients with obstructive sleep apnea.
91.	2013	Predictive factors for reintubation following noninvasive ventilation in patients with respiratory complications after living donor liver transplantation.
92.	2013	Roles of eicosanoids in pulmonary fibrosis.
93.	2013	The prognostic value of HRCT in myositis-associated interstitial lung disease.
94.	2012	Analysis of anatomical and functional determinants of obstructive sleep apnea.
95.	2012	Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study.
96.	2012	Differences in relationships among sleep apnoea, glucose level, sleep duration and sleepiness between persons with and without type 2 diabetes.
97.	2012	Expression of prostaglandin F receptor in scleral and subconjuctival tissue.
98.	2012	Impact of nasal continuous positive airway pressure for congenital adrenal hyperplasia with obstructive sleep apnea and bruxism.
99.	2012	Nocturia in male patients with obstructive sleep apnea: efficacy of medication for benign prostate hypertrophy.
100.	2012	Relationships of decreased lung function with metabolic syndrome and obstructive sleep apnea in Japanese males.
101.	2012	Streptococcus pneumoniae urinary antigen test and acute exacerbation of chronic obstructive pulmonary disease.
102.	2012	Transient increase in epileptiform discharges after the introduction of nasal continuous positive airway pressure in a patient with obstructive sleep apnea and epilepsy.
103.	2011	Airflow limitation or static hyperinflation: which is more closely related to dyspnea with activities of daily living in patients with COPD?
104.	2011	Clinical pathway for acute exacerbations of chronic obstructive pulmonary disease: method development and five years of experience.
105.	2011	Comparison of biomarkers of subclinical lung injury in obstructive sleep apnea.
106.	2011	Effects of the presence of hypertension on the relationship between obstructive sleep apnoea and sleepiness.
107.	2011	Efficacy of blood-patch pleurodesis for secondary spontaneous pneumothorax in interstitial lung disease.
108.	2011	HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody.
109.	2011	Immediate noninvasive ventilation may improve mortality in patients with hepatopulmonary syndrome after liver transplantation.
110.	2011	PaCO₂ six months after the initiation of long-term noninvasive ventilation in patients with COPD.
111.	2011	Predictive properties of different multidimensional staging systems in patients with COPD.
112.	2011	TRPA1 underlies a sensing mechanism for O₂.
113.	2011	Validation of the Japanese version of the sarcoidosis health questionnaire: A cross-sectional study.
114.	2010	Associations between obstructive sleep apnea, metabolic syndrome, and sleep duration, as measured with an actigraph, in an urban male working population in Japan.
115.	2010	Avoidance of reintubation by using sedation during noninvasive positive pressure ventilation in a 3-month-old infant with postoperative respiratory failure.
116.	2010	Effect of EP4 agonist (ONO-4819CD) for patients with mild to moderate ulcerative colitis refractory to 5-aminosalicylates: A randomized phase II, placebo-controlled trial.
117.	2010	Importance of the PaCO₂ from 3 to 6 months after initiation of long-term non-invasive ventilation.
118.	2010	Long-term nasal continuous positive airway pressure treatment lowers blood pressure in patients with obstructive sleep apnea regardless of age.
119.	2010	Multidimensional analyses of long-term clinical courses of asthma and chronic obstructive pulmonary disease.
120.	2010	Noninvasive ventilation improves the outcome of pulmonary complications after liver resection.
121.	2010	Relationship between peripheral airway function and patient-reported outcomes in COPD: a cross-sectional study.
122.	2010	Relationship between small airway function and health status, dyspnea and disease control in asthma.
123.	2009	A case of diffuse infiltrative lung disease with chronic vomiting after gastrectomy.
124.	2009	Computed tomography analysis of airway dimensions and lung density in patients with sarcoidosis
125.	2009	Effect of exacerbations on health status in subjects with chronic obstructive pulmonary disease.
126.	2009	Effects of obstructive sleep apnea with intermittent hypoxia on platelet aggregability.
127.	2009	Importance of ventilator mode in long-term noninvasive positive pressure ventilation.
128.	2009	Long-term complications and prognosis of chronic beryllium disease.
129.	2009	Prostaglandin F_2areceptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-B
130.	2008	Acylated ghrelin level in patients with OSA before and after nasal CPAP treatment.
131.	2008	Alcohol consumption in patients with chronic obstructive pulmonary disease in Japan.
132.	2008	Comparison of health-related quality of life measurements using a single value in patients with asthma and chronic obstructive pulmonary disease.
133.	2008	Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure.
134.	2007	Analysis of longitudinal changes in the psychological status of patients with asthma.
135.	2007	Longitudinal deteriorations in patient reported outcomes in patients with COPD.
136.	2006	Dyspnoea with activities of daily living versus peak dyspnoea during exercise in male patients with COPD.
137.	2005	"MORTALITY" in OUTCOMES AND MARKERS IN COPD.
138.	2005	Exercise capacity deterioration in patients with COPD: longitudinal evaluation over 5 years.
139.	2005	Longitudinal changes in patient vs. physician-based outcome measures did not significantly correlate in asthma.
140.	2004	A comparison of two simple measures to evaluate the health status of asthmatics: the Asthma Bother Profile and the Airways Questionnaire 20
141.	2004	Development and psychometric analysis of the Japanese version of the Nottingham Health Profile: cross-cultural adaptation.
142.	2004	Exercise responses during endurance testing at different intensities in patients with COPD.
143.	2004	Health-related quality of life in stable asthma: What are remaining quality of life problems in patients with well-controlled asthma?
144.	2004	Longitudinal changes in health status using the Chronic Respiratory Disease Questionnaire and pulmonary function in patients with stable COPD.
145.	2004	Possible maximal change in the SF-36 of outpatients with chronic obstructive pulmonary disease and asthma.
146.	2003	A comparison of the effects of salbutamol and ipratropium bromide on exercise endurance in patients with COPD.
147.	2003	A comparison of the responsiveness of different generic health status measures in patients with asthma.
148.	2003	Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status.
149.	2003	Optimal cutoff level of breath carbon monoxide for assessing smoking status in patients with asthma and COPD.
150.	2002	Comparison of the responsiveness of different disease-specific health status measures in patients with asthma.
151.	2002	Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with chronic obstructive pulmonary disease.
152.	2002	Health status measured with the CRQ does not predict mortality in COPD.
153.	2002	Longitudinal changes in airflow limitation and airway hyperresponsiveness in patients with stable asthma.
154.	2002	Relationship between different indices of exercise capacity and clinical measures in patients with chronic obstructive pulmonary disease.
155.	2001	A comparison of the individual best versus the predicted peak expiratory flow in patients with chronic asthma.
156.	2001	Changes in indices of airway hyperresponsiveness during one year of treatment with inhaled corticosteroids in patients with asthma
157.	2000	Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease.
158.	2000	The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests.
159.	1999	A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD.
Display 5 items
Display all(159)

■ Presentation

1.	2022/10/21	Development of automated immunoassay to detect serum biomarkers predicting response to immune checkpoint inhibitors in NSCLC （Poster notice，General）
2.	2022/08/06	Serum NY-ESO-1 and XAGE1 antibodies predict and monitor clinical responses to immune checkpoint therapy for NSCLC （Poster notice，General）
3.	2020/06/22	Development of a fully automated immunoassay system for detection of serum NY-ESO-1 and XAGE1 antibodies as biomarkers predicting the clinical efficacy of anti-PD-1 therapy （Poster notice，General）
4.	2020/06/22	Phase I study of XAGE1 peptide vaccine in patients with lung adenocarcinoma. （Poster notice，General）
5.	2020/06	Hyaluronan enhances the effect of allergen-specific sublingual immunotherapy in a dermatophagoides farina-induced mouse model of chronic asthma. （Speech，General）

■ Belonging society

1.		American Thoracic Society
2.		European Respiratory Society